Mycobacterium nebraskense as a cause of nodular pulmonary disease.
Mycobacterium nebraskense is a scotochromogenic mycobacterium first isolated from sputum samples of five patients at the University of Nebraska Medical Center. M. nebraskense was first identified as a pathogen in an immunocompetent host, also in Nebraska. In this case report, we describe a patient with nodular pulmonary disease most likely due to M. nebraskense, who was successfully treated with rifampin and azithromycin, representing the first case in which this organism was a pathogen outside of Nebraska and the first description of successful treatment of this infection.
Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, Georgia, USA.
Swathy
S
Puthalapattu
Mark L
ML
Metersky
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D003237:Connecticut; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification*; D012293:Rifampin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D015607:Stents; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D017963:Azithromycin; D012293:Rifampin